C4 Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -34.10M-66.33M-83.89M-128.18M-132.49M-105.32M
Depreciation and Depletion 1.59M1.62M1.49M1.68M1.58M1.47M
Share-based Compensation 1.64M3.43M21.51M30.02M27.23M29.66M
Gains from Investment Securities 2.31M5.68M20.13M44.07M
Non-cash Items 4.80M102.64M1.36M
Cash from Operations 55.61M-67.25M-86.97M-105.94M-106.84M-65.16M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.14M1.22M-1.88M5.90M6.16M6.42M
Depreciation & Amortization (CF) 1.59M1.62M1.49M1.68M1.88M1.82M
Change in Working Capital
Change in Receivables -81.81M-0.14M1.23M-4.24M10.33M-8.70M
Change in Account Payables 4.23M0.47M-1.18M-3.33M0.27M-0.12M
Change in Accured Expenses 3.72M2.56M4.38M5.08M1.32M-1.27M
Investing Activities
Capital Expenditures 1.35M0.65M1.28M5.50M1.71M0.18M
Sales of Property, Plant and Equipment 0.06M
Change in Acquisitions & Divestments 78.67M104.00M349.68M283.44M289.95M233.23M
Cash from Investing Activities -1.62M-190.50M-189.34M58.42M158.35M-51.27M
Financing Activities
Other financing activities -0.11M0.37M0.37M0.38M
Change in Capital Stock
Shares Issued 0.27M195.07M2.33M0.78M0.06M0.78M
Shares Repurchased 0.03M0.19M0.11M0.19M
Preferred Shares Issued 145.53M150.00M
Misc.
Cash from Financing Activities 0.24M348.93M171.40M1.15M45.49M45.34M
Change in Cash 54.24M91.18M-104.90M-46.37M97.00M-71.09M
Beginning Cash Balance 12.50M
Free Cash Flow 54.27M-67.90M-88.24M-111.44M-108.55M-65.34M
Net Cash Flow 54.24M91.18M-104.90M-46.37M97.00M-71.09M